SCHEMBL21580197

SCHEMBL21580197

CC1(O)CCOC(c2ccco2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
CHRM2 P08172 6/20 0.33
CHRM4 P08173 6/20 0.33
CHRM5 P08912 6/20 0.33
CHRM1 P11229 6/20 0.33
CHRM3 P20309 6/20 0.33
TRPA1 O75762 1/20 0.33
POLB P06746 2/20 0.33
MAPT P10636 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
KMT2A Q03164 1/20 0.33
ADORA2B P29275 3/20 0.32
CYP2C19 P33261 1/20 0.32
APOBEC3A P31941 1/20 0.32
RECQL P46063 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28687188 0.81 NPC1 (0.37) NPC1ALDH1A1KDM4EHSD17B10NPSR1
SCHEMBL21580196 0.79 NPC1 (0.35) NPC1ALDH1A1KDM4EHSD17B10NPSR1
SCHEMBL23625193 0.76 OPRK1 (0.38) NPC1ALDH1A1KDM4EHSD17B10NPSR1
SCHEMBL21580199 0.76 KDM4E (0.38) NPC1ALDH1A1KDM4ENPSR1POLB
SCHEMBL21580202 0.76 ADORA2B (0.35) NPC1ALDH1A1KDM4EHSD17B10POLB
SCHEMBL156075 0.76 TRPA1 (0.50) ALDH1A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL17696721 0.76 TRPA1 (0.50) ALDH1A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL17696719 0.76 TRPA1 (0.50) ALDH1A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL17696718 0.76 TRPA1 (0.50) ALDH1A1CHRM2CHRM4CHRM1CHRM3
SCHEMBL17696722 0.76 TRPA1 (0.50) ALDH1A1CHRM2CHRM4CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112204122-B 2-Furyl-and 2-thienyl-substituted dihydropyran and tetrahydropyran as aromatic chemicals 巴斯夫欧洲公司 2025-01-07 CN disclosed
EP-3802758-B1 2-FURYL- AND 2-THIENYL-SUBSTITUTED DI- AND TETRAHYDROPYRANS FOR USE AS AROMA CHEMICALS BASF SE (DE) 2024-12-04 EP disclosed
US-11993760-B2 2-furyl- and 2-thienyl-substituted di- and tetrahydropyrans for use as aroma chemicals BASF SE (DE) 2024-05-28 US disclosed
US-20210207057-A1 2-FURYL- AND 2-THIENYL-SUBSTITUTED DI- AND TETRAHYDROPYRANS FOR USE AS AROMA CHEMICALS BASF SE (DE) 2021-07-08 US disclosed
US-20210207057-A1 2-FURYL- AND 2-THIENYL-SUBSTITUTED DI- AND TETRAHYDROPYRANS FOR USE AS AROMA CHEMICALS BASF SE (DE) 2021-07-08 US disclosed
EP-3802758-A1 2-FURYL- AND 2-THIENYL-SUBSTITUTED DI- AND TETRAHYDROPYRANS FOR USE AS AROMA CHEMICALS BASF SE (DE) 2021-04-14 EP disclosed
CN-112204122-A 2-furyl-and 2-thienyl-substituted dihydropyrans and tetrahydropyrans as fragrance chemicals 巴斯夫欧洲公司 2021-01-08 CN disclosed
WO-2019224373-A1 2-FURYL- AND 2-THIENYL-SUBSTITUTED DI- AND TETRAHYDROPYRANS FOR USE AS AROMA CHEMICALS BASF SE (DE) 2019-11-28 WO disclosed
WO-2019224373-A1 2-FURYL- AND 2-THIENYL-SUBSTITUTED DI- AND TETRAHYDROPYRANS FOR USE AS AROMA CHEMICALS BASF SE (DE) 2019-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210207057-A1 2-FURYL- AND 2-THIENYL-SUBSTITUTED DI- AND TETRAHYDROPYRANS FOR USE AS AROMA CHEMICALS TRPA1, TAS2R5, TAS2R3 NPC1 4154/4885ALDH1A1 72/4885KDM4E 1940/4885
US-11993760-B2 2-furyl- and 2-thienyl-substituted di- and tetrahydropyrans for use as aroma chemicals TRPA1, TAS2R5, TAS2R3 NPC1 4154/4885ALDH1A1 72/4885KDM4E 1940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.